Infliximab

Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research.


Cat. No.: EX-A6991	Purity: >98%

	Chemical structure of Infliximab

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
10mg	550	In-stock
25mg	get quote	In-stock
50mg	get quote	In-stock
100mg	get quote	In-stock
200mg	get quote	In-stock
500mg	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Avakine
Synonyms 2	CT-P13
CAS No.	170277-31-3
Purity	>98%
Color	White to off-white
State	powder
Storage	Lyophilized Infliximab store at -20℃. Upon dissolve, The product should be stored at 4℃ and is stable for 1 month
Shipping	Shipping with dry ice.

Reference:	[1]. Lucia A Méndez-García, et al. Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro. Scand J Immunol. 2018 Nov;88(5):e12716. [2]. Isamu Yamakawa, et al. Inactivation of TNF-α ameliorates diabetic neuropathy in mice. Am J Physiol Endocrinol Metab. 2011 Nov;301(5):E844-52.
CoA	CoA of Infliximab


		Search